LINEAR OR CYCLIC PEPTIDES, THEIR USING AND METHOD OF PATIENT TREATMENT Russian patent published in 1999 - IPC

Abstract RU 2130317 C1

FIELD: chemistry of peptides, medicine, pharmacy. SUBSTANCE: linear or cyclic peptide of the general formula: D-Ala-Ser-Thr-Thr-Thr-Asn-Tyr-Thr-NH2 or its derivative or its salt is used for production of drug designated for treatment and prophylaxis of patients with intestine inflammatory diseases. Method involves administration to patient an effective amount of peptide - from 0.05 to 1000 mg peptide per a day. Peptide is administrated as a pharmaceutical composition in combination with pharmaceutically acceptable carrier. Pharmaceutically acceptable carriers are taken from carriers that make a composition to be suitable for intranasal administration, for oral, buccal, parenteral, local or rectal route of administration or by inhalation. EFFECT: enhanced effectiveness of patient treatment. 13 cl, 17 dwg, 14 tbl, 27 ex

Similar patents RU2130317C1

Title Year Author Number
COMPOSITIONS AND METHODS USED FOR ASSESSING CYTOTOXICITY OF SINGLE CELLS 2009
  • Lav Dzhon Kristofer
  • Varadaradzhan Navin
  • Jul'G Boris
  • Uolker Brjus
RU2532228C2
STEM CELL PROLIFERATION INHIBITOR AND STIMULANT AND USAGE THEREOF 1997
  • Uolp Stefen D.
  • Tsirlova Irina
RU2292352C9
METHODS FOR IMMUNOTHERAPY WITH CHIMERIC ANTIGEN RECEPTOR IN COMBINATION WITH 4-1BB AGONIST 2019
  • Go, William Y.
  • Woolfson, Adrian
RU2788524C2
METHODS OF EXPANSION OF ANTIGEN-SPECIFIC CAR-T-CELLS, COMPOSITIONS AND THEIR USE 2019
  • Aftab, Blake, T.
  • Pham, Christina
  • Shen, Rhine
  • Wu, Michelle
RU2800920C2
COMBINATION THERAPY WITH SEMAFORIN 4D (SEMA4D) BLOCKING AND DC1 THERAPY 2020
  • Charnetski, Brajan
  • Kodumudi, Kritika
  • Evans, Elizabet
RU2801828C2
BISPECIFIC MOLECULES, IMMUNOREACTIVE WITH IMMUNE EFFECTOR CELLS EXPRESSING AN ACTIVATING RECEPTOR 2014
  • Kenig, Skott
  • Dzhonson, Lesli S.
  • Lam, Chia-In Kao
  • Lyu, Litsin
  • Nordstrom, Dzheffri Li
  • Khejns, Barton F.
  • Ferrari, Gvido
RU2721707C2
DRUGS FOR TREATING DISEASES 2010
  • Osterrot Frank
  • Uerek Kristof
  • Bryukher Kristof
  • Delken Benzhamin
  • Engling Andre
  • Tsuber Shantal
  • Chelot Niklas
  • Vallmajer Kholger
  • Felp Kirsten
  • Shults Gregor
RU2598719C2
CHAPERONIN 10 MODULATION OF TOLL-LIKE RECEPTOR INDUCIBLE CYTOKINE AND CHEMOKINE SECRETION 2005
  • Dzhonson Barbara Dzhejn
  • Zurbir Andreas
  • Nehjlor Din Dzhejson
  • Dobbin Kehrolajn Amanda
  • Khovard Kristofer Brjus
RU2446817C2
NOVEL ANTI-PD-L1 ANTIBODIES 2016
  • Chzhen Yun
  • Li Tszin
  • Chen Chzhishen
RU2736151C2
TREATMENT AND FUNCTIONAL CURE OF HIV-INFECTION WITH MONOCLONAL ANTIBODIES TO CD4 MEDIATING COMPETITIVE INHIBITION OF HIV ENTRY 2014
  • Van Chan I
RU2762315C2

RU 2 130 317 C1

Authors

Anders Dzhorgen Andersen

Rodzher Aston

Piter Lui Karlen

Penelop Rid Dub

Duglas Kevin Makfadden

Dehvid Dzhejms Fipps

Debora Ratdzhen

Fred Vidmer

Dates

1999-05-20Published

1993-03-29Filed